Glenmark to release Indacaterol + Mometasone fixed-dose mixture drug for Asthma in India

Glenmark to release Indacaterol + Mometasone fixed-dose mixture drug for Asthma in India

by admin- Thursday, June 16th, 2022 03:45:10 PM

Glenmark Pharmaceuticals launched the unconventional fixed-dose combination (FDC) drug – Indacaterol + Mometasone for sufferers affected by out of control asthma, in India. The agency has released this FDC below the logo name Indamet. The drug might be available in 3 strengths with a hard and fast dose of Indacaterol 150 mcg and variable doses of Mometasone eighty mcg, one hundred sixty mcg, and 320 mcg respectively, to be taken once every day.

News Updates